Continuous Glucose Monitoring (CGM): Technologies and Global Markets

Published - Jan 2018| Analyst - Valerie Kellogg| Code - HLC102C
Continuous Glucose Monitoring (CGM): Technologies and Global Markets
Single User License: $5500 Member Price: FREE

Report Highlights

The global market for continuous glucose monitoring devices and diabetes-related products totaled nearly $12.1 billion in 2016. The market should reach nearly $12.8 billion in 2017 and $20.7 billion in 2022, registering a compound annual growth (CAGR) of 10.1% from 2017-2022.

Report Includes

  • 52 data tables and 20 additional tables
  • An overview of the global market for continuous glucose monitoring (CGM)
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Examination of the critical issues within the CGM market, including technological developments, geographic trends, market dynamics, and adoption trends
  • Market breakdowns by application area: hospitals, diagnostics/clinics, home
  • Information broken down by age: children, teens, young, middle, elderly; by race: non-Hispanic whites, Hispanics, Asian-Americans, Europeans, Asians, others; and by geography: the U.S., Europe, Asia, and the rest of the world
  • Information on leading companies, including Abbott Labs, Apple Inc., Johnson & Johnson, Medella Health, Medtronic, Roche, Sanofi and Unilife Corp

Report Scope

The scope of this study encompasses the current and forecast markets for glucose monitoring, as well as pumps, SMBG meters and test strips. The covered segments are CGM transmitters, receivers and sensors, patch and durable insulin pumps, and self–monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all usage of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM device. Calibration may be required once or twice a day, or even less often, as the devices improve in the near future. Inclusion of SMBG meters and test strips will help the reader to comprehend the relative sizes of the two major segments: CGM and SMBG. As discussed elsewhere in this report, developing countries will continue to use primarily SMBG, as these devices are not only much cheaper than CGM, but, for many diabetics, do just fine for monitoring blood glucose. The report also includes discussions of the reimbursement and regulatory environments, current and developing technologies, diabetes incidence, market projections and market shares, and the latest trends and clinical trials.

Analyst Credentials

Valerie Kellogg is an experienced medical device and pharmaceutical professional with international market research experience. She has authored numerous reports on topics ranging from the treatment of obesity to ablation devices, from wound care to the treatment of chronic migraine. Her strong focus areas include oncology, treatment of chronic disease, the latest in surgical devices and analysis of potential acquisitions. 

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Nov-2014| Analyst - Valerie Kellogg| Code - HLC102B

Report Highlights

The global market for continuous glucose monitoring products totaled $279.4 million in 2013. This market reached $320.9 million in 2014 and is expected to reach $783.9 million in 2019, registering a compound annual growth (CAGR) of 19.6% from 2014-2019.

Report Includes

  • An overview of the global market for continuos glucose monitoring (CGM).
  • Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Examination of the critical issues of the CGM market including technological developments, geographic trends, market dynamics and adoption trends
  • Market breakdowns by application area: hospitals, diagnostics/clinics, home
  • Information broken down by age: children, teens, young, middle, elderly; by race: non-Hispanic whites, Hispanics, Asian Americans, Europeans, Asians, others; and by geography: the U.S., Europe, Asia, and the rest of the world
  • Receive information on leading companies including their product portfolios and recent developments.

Published - Jun-2012| Analyst - Varsha Bhat| Code - HLC102A

Report Highlights

The global market for continuous glucose monitoring (CGM) devices was worth $165.8 million in 2010 and $183.7 million in 2011. This market is projected to reach $356.5 million by 2016, with a five-year compound annual growth rate (CAGR) of 14.2% from 2011 through 2016.

CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report